ACTIONS OF PLATELET-DERIVED GROWTH-FACTOR ISOFORMS IN MESANGIAL CELLS

被引:33
作者
ABBOUD, HE
GRANDALIANO, G
PINZANI, M
KNAUSS, T
PIERCE, GF
JAFFER, F
机构
[1] AMGEN INC,DEPT EXPTL PATHOL,THOUSAND OAKS,CA 91320
[2] CASE WESTERN RESERVE UNIV,DEPT MED,CLEVELAND,OH 44106
关键词
D O I
10.1002/jcp.1041580118
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Platelet-derived growth factor (PDGF) occurs as homodimers or heterodimers of related polypeptide chains PDGF-BB, -AA, and -AB. There are two receptors that bind PDGF termed alpha and beta. The beta receptor recognizes PDGF B chain and is dimerized in response to PDGF BB. The alpha receptor recognizes PDGF B as well as A chains and can be dimerized by the three dimeric forms of PDGF AA, AB, and BB. To characterize PDGF receptor signaling mechanisms and biologic activities in human mesangial cells (MC), we explored the effects of the three PDGF isoforms on DNA synthesis, phospholipase C activation, and PDGF protooncogene induction. PDGF-BB homodimer and AB heterodimer induced a marked increase in DNA synthesis, activation of phsopholipase C, and autoinduction of PDGF A and B chain mRNAs, whereas PDGF-AA homodimer was without effect. The lack of response to PDGF AA could be accounted for by down-regulation of the PDGF-alpha receptor since preincubation of MC with suramin restored PDGF AA-induced DNA synthesis. Ligand binding studies demonstrate specific binding of labeled PDGF BB and AB and to a lower extent PDGF AA isoforms to mesangial cells. These results are consistent with predominant expression of PDGF beta receptor in MC, which is linked to phospholipase-C activation. The potent biologic effects of PDGF-AB heterodimer in cells that express very few alpha receptors and do not respond to PDGF AA are somewhat inconsistent with the currently accepted model of PDGF receptor interaction and suggest the presence of additional mechanisms for PDGF isoform binding and activation.
引用
收藏
页码:140 / 150
页数:11
相关论文
共 50 条
[31]   PLATELET CONTENT AND RELEASE OF PLATELET-DERIVED GROWTH-FACTOR [J].
VISSINGER, H ;
HUSTED, SE ;
KRISTENSEN, SD ;
NIELSEN, HK .
THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) :1157-1157
[32]   EXTRACELLULAR CALCIUM MIMICS THE ACTIONS OF PLATELET-DERIVED GROWTH-FACTOR ON MOUSE FIBROBLASTS [J].
EPSTEIN, RJ ;
DRUKER, BJ ;
IRMINGER, JC ;
JONES, SD ;
ROBERTS, TM ;
STILES, CD .
CELL GROWTH & DIFFERENTIATION, 1992, 3 (03) :157-164
[33]   THE REGULATION OF EPIDERMAL GROWTH-FACTOR RECEPTORS BY PLATELET-DERIVED GROWTH-FACTOR [J].
WHARTON, W ;
LEOF, E ;
PLEDGER, WJ ;
OKEEFE, E .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1982, 397 (DEC) :325-326
[34]   PLATELET-DERIVED GROWTH-FACTOR IS CHEMOTACTIC FOR FIBROBLASTS [J].
SEPPA, H ;
GROTENDORST, G ;
SEPPA, S ;
SCHIFFMANN, E ;
MARTIN, GR .
JOURNAL OF CELL BIOLOGY, 1982, 92 (02) :584-588
[35]   HUMAN MESANGIAL CELLS RELEASE A PLATELET-DERIVED GROWTH-FACTOR (PDGF)-LIKE MOLECULE AND PROLIFERATE IN RESPONSE TO PDGF [J].
SHULTZ, P ;
DICORLETO, P ;
ABBOUD, HE .
KIDNEY INTERNATIONAL, 1987, 31 (01) :182-182
[36]   MITOGENIC EFFECT OF PLATELET-DERIVED GROWTH-FACTOR IN HUMAN GLOMERULAR MESANGIAL CELLS - MODULATION AND OR SUPPRESSION BY INFLAMMATORY CYTOKINES [J].
FLOEGE, J ;
TOPLEY, N ;
HOPPE, J ;
BARRETT, TB ;
RESCH, K .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1991, 86 (02) :334-341
[37]   PURIFICATION OF HUMAN PLATELET-DERIVED GROWTH-FACTOR [J].
RAINES, EW ;
ROSS, R .
METHODS IN ENZYMOLOGY, 1985, 109 :749-773
[38]   PURIFICATION OF HUMAN PLATELET-DERIVED GROWTH-FACTOR [J].
MACIAG, T .
TRENDS IN BIOCHEMICAL SCIENCES, 1982, 7 (08) :270-270
[39]   PLATELET-DERIVED GROWTH-FACTOR IN EXPERIMENTAL GLOMERULONEPHRITIS [J].
ZHANG, G ;
ELNAHAS, AM .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 (06) :787-795
[40]   A RADIORECEPTOR ASSAY FOR PLATELET-DERIVED GROWTH-FACTOR [J].
SINGH, JP .
METHODS IN ENZYMOLOGY, 1987, 147 :13-22